Prometheus Biosciences Rings The Nasdaq Stock Market Closing Bell In Celebration of its One Year Anniversary
Prometheus Biosciences (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, rings the closing bell at the Nasdaq MarketSite in Times Square. The bell ringing ceremony is to commemorate the company’s one year anniversary as a public company and to celebrate being the top-performing biotech IPO in 2021.